Page last updated: 2024-09-04

resiquimod and chitosan

resiquimod has been researched along with chitosan in 2 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(chitosan)
Trials
(chitosan)
Recent Studies (post-2010) (chitosan)
4651431827,64823221,257

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Buffa, V; Doyle-Meyers, L; Fischetti, L; King, DF; Klein, K; Shattock, RJ; Siddiqui, A; Tregoning, JS; Veazey, RS1
Abdolalizadeh, J; Amini, Y; Azizian, K; Baradaran, B; Gholizadeh, P; Hasani, A; Hoseinpur, R; Memar, MY; Salehi, R; Samadi Kafil, H1

Other Studies

2 other study(ies) available for resiquimod and chitosan

ArticleYear
Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
    Human vaccines & immunotherapeutics, 2015, Volume: 11, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies; Antibody Formation; beta-Galactosidase; Chitosan; Cytokines; Female; Hemocyanins; Imidazoles; Immunity, Mucosal; Immunization; Immunoglobulin A; Immunoglobulin G; Inflammation; Injections, Intramuscular; Lipopeptides; Macaca mulatta; Mucous Membrane; Ovalbumin; Poly I-C; Thymic Stromal Lymphopoietin

2015
Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
    Journal of biomaterials applications, 2022, Volume: 37, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Bacterial Proteins; BCG Vaccine; Chitosan; Escherichia coli; Imidazoles; Immunoglobulin G; Interleukin-17; Interleukin-4; Mice; Mycobacterium tuberculosis; Nanoparticles; Tuberculosis

2022